Automation and collaboration can increase R&D productivity

Pharmaceutical companies can increase their R&D productivity through automation and collaboration, according to Eric Paternoster, Senior Vice President and Head, Insurance, Healthcare and Life Sciences, Infosys. In an article for Applied Clinical ... Trials Online, Eric says that companies must standardize data and protocols to enable interoperability and ensure effective collaboration. Automation and re-design of clinical trial processes can reduce study time, costs and errors. Eric believes that effective information management across the clinical development process extracts insights leading to new drugs.

 

This article has been reproduced with the permission of Applied Clinical Trials magazine.

Accelerating Drug Discovery and Time-To-Market

A leading pharmaceutical company partnered with Infosys and Microsoft to develop an Office Business Application. It enables research biologists to sort through a large volume of data, analyze it, and share results with other scientists worldwide. The application... accelerates the process of developing new drugs and helps the company bring drugs to the market faster.

Grid Computing Accelerates Gene Discovery Research

Pharmaceutical companies are under constant pressure to improve time-to-market and reduce costs of producing novel drug molecules. Infosys' Discovery Research Workflow on Grid (DRWG) solution helps you automate and accelerate... gene discovery research. It leverages grid computing to offer cost savings, faster time-to-market, enhanced collaboration and optimal use of existing computing resources

Pharma IT: Pushing the Boundaries of R&D

Increasingly, pharma organizations are turning to IT to create a global collaborative work environment and control the cost of drug development. To ensure productivity and regulatory compliance, IT processes need to be transformed... Pharmaceutical IT projects must look beyond IT requirements while delivering the required software. Learn how pharma companies can deliver the right products and meet the needs of stakeholders.

 

© Reprinted from JOURNAL OF GXP COMPLIANCE, July 2007. All Rights Reserved. Used by Permission.

'Life sciences organizations will increase their use of strategic outsourcing'

In an interview with Bio-IT World, Eric Paternoster, Life Sciences Business Unit Head, Infosys Technologies stated that life sciences companies need to better use the vast amount of information they gather to remain competitive. According to... Eric, "Life sciences organizations will increase their use of strategic outsourcing to improve competitiveness, outsourcing not just the development and maintenance of IT applications, but also business processes such as safety management and submissions. Emerging software delivery models such as SaaS (software as a service) will change the way the life sciences industry uses IT."

Related Information

Press Release

AstraZeneca awards Infosys Technologies multi-year, multi-million dollar global services deal.

More

 

In the News

Sourcing at your fingertips:
Global Sourcing Essentials
Everything you wanted to know about global sourcing, in five easy parts.
Download your copy

Copyright © 2009 Infosys Technologies Limited

Privacy Statement | Safe Harbor Provision | Terms of use | Trademarks